New Bipartisan Bill Aims for 10-Year SBIR/STTR Reauthorization
A bipartisan bill to reauthorize the SBIR/STTR programs for a decade is advancing in the Senate. Introduced by Senators Joni Ernst and Ed Markey, the Small Business Innovation and Economic Security Act is being hailed as a "once-in-a-decade gift" for small innovators, with potential upgrades to IP protection and commercialization incentives.
The Small Business Innovation Research (SBIR) program, established in 1982, and the Small Business Technology Transfer (STTR) program, created in 1992, require periodic reauthorization by Congress. The latest extension, the SBIR and STTR Extension Act of 2022, is set to expire on September 30, 2025. Historically, reauthorization has often been a contentious process, with a notable lapse in program authority occurring in the fall of 2025, which halted new activity across 11 federal agencies. The current legislative push follows months of gridlock over proposed reforms. Key debates have centered on concerns about a small number of "multi-award winners" (MAWs), sometimes called "SBIR Mills," receiving a disproportionate amount of funding without necessarily achieving commercial success. A 2024 GAO report found that while MAWs represent less than 1% of participants, they receive over 10% of Phase II funding and have performed at or below peers on metrics like patents and private-sector sales. The "Small Business Innovation and Economic Security Act" aims to address these issues by requiring agencies to set annual limits on the number of proposals a single company can submit. This is a compromise from an earlier proposal in the INNOVATE Act, which sought a lifetime cap on awards. The bill also includes provisions to strengthen due diligence and guard against foreign influence, particularly from China. A significant new provision in the bill is the creation of a "strategic breakthrough award." This post-Phase II initiative would allow agencies to grant larger awards, potentially up to $30 million, to help companies scale and cross the "valley of death" between research and commercial viability. The legislation also mandates enhanced training for the federal acquisition workforce on awarding Phase III contracts, which are funded by government procurement or private capital, not SBIR funds. The SBIR/STTR programs are a major source of non-dilutive funding for startups, providing over $4 billion annually to more than 4,000 companies. The Department of Defense is the largest participant, awarding approximately $1 billion in SBIR grants each year. These programs are structured in phases: Phase I for feasibility (up to about $314,000), Phase II for prototype development (up to about $2.1 million), and Phase III for commercialization. Previous reauthorizations have also introduced significant changes. The 2022 extension, for example, added new disclosure requirements for companies with ties to foreign countries of concern and mandated that the DoD establish "open topic" announcements to attract a wider range of commercial technologies. The ongoing debate reflects a fundamental tension between supporting experienced R&D firms and ensuring the program serves its original purpose of seeding a broad base of new innovators.
